Assess whether working capital should be a walk-away (72ea75)

SITUATION A customer who just sent a non-renewal put regulatory-approval critical-path calendar in front of working-capital true-up analyst in a strategic buyer looking at a carve-out from a conglomerate. This M&A Due Diligence / Legal, IP, and Regulatory close is working capital should be from regulatory-approval critical-path calendar, and the live options are Proceed, Reprice, Walk.

DECISION Working-capital true-up analyst in a strategic buyer looking at a carve-out from a conglomerate must choose Proceed / Reprice / Walk / Hold using regulatory-approval critical-path calendar after a customer who just sent a non-renewal.

HYPOTHESES TO TEST 1. A customer who just sent a non-renewal is noise around an already-controlled Legal, IP, and Regulatory process in a strategic buyer looking at a carve-out from a conglomerate, given regulatory-approval critical-path calendar. 2. A customer who just sent a non-renewal is the event in regulatory-approval critical-path calendar that forces Proceed for working-capital true-up analyst under M&A Due Diligence. 3. Regulatory-approval critical-path calendar shows a one-file miss after a customer who just sent a non-renewal, not a Legal, IP, and Regulatory program failure. 4. Regulatory-approval critical-path calendar cannot decide working capital should be yet after a customer who just sent a non-renewal; hold is the only M&A Due Diligence close a strategic buyer looking at a carve-out from a conglomerate can defend.

ANALYSIS REQUIRED 1. Test whether a customer who just sent a non-renewal is a diligence gap, a price chip, or a walk-away. 2. Separate a one-off add-back from a recurring earnings issue in regulatory-approval critical-path calendar. 3. Map reps, earnout mechanics, and integration risk a strategic buyer looking at a carve-out from a conglomerate would inherit. 4. For this M&A Due Diligence Legal, IP, and Regulatory file, read regulatory-approval critical-path calendar against a customer who just sent a non-renewal and write the one fact that would move working capital should be for working-capital true-up analyst.

RECOMMENDATION Choose Proceed / Reprice / Walk / Hold on this M&A Due Diligence / Legal, IP, and Regulatory packet (regulatory-approval critical-path calendar after a customer who just sent a non-renewal). If regulatory-approval critical-path calendar cannot force a M&A Due Diligence label under Legal, IP, and Regulatory, stop. If regulatory-approval critical-path calendar after a customer who just sent a non-renewal cannot support Proceed versus Reprice on this M&A Due Diligence Legal, IP, and Regulatory close, working-capital true-up analyst must do not proceed, reprice, or walk on a quality-of-earnings fact the packet does not carry.